CRIS is really behaving in a very strange manner. If I were a psychologist diagnosing a human being, I would say that it is the behavioural pattern of a schezhophrenic. I certainly hope some positive news will be forthcoming, otherwise it will be languishing around $5 for a long, long time. And if EU approval is denied, I would not be surprised that CRIS will go south, so don't start planning celebration parties, since there may be nothing to celebrate. Don't forget that CRIS has a loss of $19 per share or rather $20 for the last fiscal year. It is a good thing that they have assets worth over 66 Million USD, a 7.6 mil USD yearly revenue from Australia alone is not going to lift the company in any meaningful way, it is of course my personal opinion.